Bob G. Gower, Director at Ensysce Biosciences, Inc. (ENSC), bought 379,300 shares at $0.49 ($183K) on 2023-02-28, disclosed to the SEC on 2023-03-02.
Open-market purchase of $183k ENSC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.49 | 109,300 | $54K | 29.2% |
| 2 | $0.48 | 270,000 | $130K | 70.8% |
| Total | $0.48 avg | 379,300 | $183K | 100% |
| Filing → |
| ENSC | BUY | 2023-02-01 | $1.0M | — | Filing → |
| MILL | BUY | 2015-01-06 | $43K | — | Filing → |
| MILL | BUY | 2014-12-22 | $76K | — | Filing → |